<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

Destination

2025-03-07

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical trials for its experimental weight-loss drug, Discover Copy

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

thenextweb

2025-01-10

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Match Score: 92.87

Destination

2025-03-06

Big Pharma wants to bring back a tax break that could save it $15 billion

Big Pharma is pushing to bring back a tax break that could have saved them at least $15.4 billion in 2023 alone, according to a new analysis by Americans for Tax Fairness (ATF) and Lower Drug Prices N [...]

Match Score: 79.55

Destination

2025-03-28

Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news roundup

Novo Nordisk is expanding its cash-only savings program offering its blockbuster weight-loss drug Wegovy for $499 a month at all U.S. pharmacies. 23andMe has filed for Chapter 11 bankruptcy protection [...]

Match Score: 79.40

Destination

2025-01-31

Get four Apple AirTags for $70, plus the rest of this week's best tech deals

It's time for another edition of Engadget's weekly deals roundup where we bring together worthwhile tech deals from the past week. If you're in the market for home entertainment gear, y [...]

Match Score: 75.89

Destination

2025-04-14

Pfizer just had a big setback in its race for an Ozempic competitor

Pfizer (PFE) announced Monday that it is ending development of its daily weight-loss pill following a liver injury to a patient participating in a trial.Read more... [...]

Match Score: 64.79

Destination

2025-03-27

Wegovy sales took a hit this year. Novo's CEO blames off-brand competition

Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy took a hit due to rising competition from off-brand, or compounded, versions of the treatment, according to the Danish pharma giantâ [...]

Match Score: 59.24

blogspot

2024-11-08

Ahrefs vs SEMrush: Which SEO Tool Should You Use?

SEMrush and Ahrefs are among<br /> the most popular tools in the SEO industry. Both companies have been in<br /> business for years and have thousands of customers per month.<br /> & [...]

Match Score: 52.60

Destination

2025-01-17

Wegovy and Ozempic top list of 15 drugs up for next price negotiations

If the Trump admin doesn't alter the process, negotiated prices will go into effect in 2027. [...]

Match Score: 50.21

Destination

2025-03-24

Novo Nordisk's weight loss drug Wegovy is now cheaper for even more patients

Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the price of its weight loss drug by more than half for even more patients that pay without insurance.Read more... [...]

Match Score: 50.19